SURF screening tool to determine suitability of using real-world evidence.
Join Laura Dormer (Editor, The Evidence Base) as she explores the US FDA’s regulatory approach to real-world data and non-randomized studies in product applications, and discusses the new publication, ‘SURF: A Screening Tool (for Sponsors) to Evaluate Whether Using Real-World Data to Support an Effectiveness Claim in an FDA Application Has Regulatory Feasibility.’